Semaglutide is a GLP-1 receptor agonist. It works with a naturally occurring hormone pathway that helps regulate appetite and signal fullness, which can support a provider-guided weight-management plan.
Compounded semaglutide is prepared to order by a licensed U.S. compounding pharmacy. It is not FDA-approved and requires a prescription from a licensed provider.
- Targets the GLP-1 receptor to help regulate appetite and signal fullness
- Taken as a once-weekly subcutaneous injection
- Your provider sets your starting dose and guides titration over time
- Used alongside lifestyle changes and continued provider care
Compounded semaglutide is not FDA-approved and is not the same as any brand-name medication. A licensed provider determines eligibility. Individual results vary.